94 related articles for article (PubMed ID: 20227890)
1. Evidence that cervical cancer cells secrete IL-2, which becomes an autocrine growth factor.
Rangel-Corona R; Corona-Ortega T; Soto-Cruz I; López-Labra A; Pablo-Arcos T; Torres-Guarneros CF; Weiss-Steider B
Cytokine; 2010 Jun; 50(3):273-7. PubMed ID: 20227890
[TBL] [Abstract][Full Text] [Related]
2. A novel role of metalloproteinase in cancer-mediated immunosuppression.
Sheu BC; Hsu SM; Ho HN; Lien HC; Huang SC; Lin RH
Cancer Res; 2001 Jan; 61(1):237-42. PubMed ID: 11196168
[TBL] [Abstract][Full Text] [Related]
3. Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth.
Lin WC; Yasumura S; Suminami Y; Sung MW; Nagashima S; Stanson J; Whiteside TL
J Immunol; 1995 Nov; 155(10):4805-16. PubMed ID: 7594483
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours.
García-Vázquez MD; Boyano MD; Cañavate ML; Gardeazabal J; de Galdeano AG; López-Michelena T; Ratón JA; Izu R; Díaz-Ramón JL; Díaz-Pérez JL
Eur Cytokine Netw; 2000 Dec; 11(4):654-61. PubMed ID: 11125310
[TBL] [Abstract][Full Text] [Related]
5. Cationic liposomes bearing IL-2 on their external surface induced mice leukocytes to kill human cervical cancer cells in vitro, and significantly reduced tumor burden in immunodepressed mice.
Rangel-Corona R; Corona-Ortega T; del Río-Ortiz I; Nieves-Ramírez ME; Morán-Bañuelos H; González-Tenorio O; Cáceres-Cortés JR; Weiss-Steider B
J Drug Target; 2011 Feb; 19(2):79-85. PubMed ID: 20367025
[TBL] [Abstract][Full Text] [Related]
6. Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells.
Trentin L; Zambello R; Benati C; Cassatella M; Agostini C; Bulian P; Adami F; Carra G; Pizzolo G; Semenzato G
Cancer Res; 1992 Oct; 52(19):5223-8. PubMed ID: 1394125
[TBL] [Abstract][Full Text] [Related]
7. Functional expression of interleukin 2 receptor in a human factor-dependent megakaryoblastic leukemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptor.
Kanakura Y; Sugahara H; Mitsui H; Ikeda H; Furitsu T; Yagura H; Kitayama H; Kanayama Y; Matsuzawa Y
Cancer Res; 1993 Feb; 53(3):675-80. PubMed ID: 8425202
[TBL] [Abstract][Full Text] [Related]
8. Regulation of interleukin-2 and interleukin-4 receptor expression in human and ape lymphoid cell lines.
Guizani L; Lang P; Stancou R; Bertoglio J
Lymphokine Cytokine Res; 1993 Feb; 12(1):25-32. PubMed ID: 8457629
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2-dependent autocrine proliferation in T-cell development.
Toribio ML; Gutiérrez-Ramos JC; Pezzi L; Marcos MA; Martínez C
Nature; 1989 Nov; 342(6245):82-5. PubMed ID: 2812004
[TBL] [Abstract][Full Text] [Related]
10. Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.
Weidmann E; Sacchi M; Plaisance S; Heo DS; Yasumura S; Lin WC; Johnson JT; Herberman RB; Azzarone B; Whiteside TL
Cancer Res; 1992 Nov; 52(21):5963-70. PubMed ID: 1394222
[TBL] [Abstract][Full Text] [Related]
11. IL-2-dependent proliferation of murine T cells requires expression of both the p55 and p70 subunits of the IL-2 receptor.
Jankovic DL; Rebollo A; Kumar A; Gibert M; Thèze J
J Immunol; 1990 Dec; 145(12):4136-44. PubMed ID: 2258612
[TBL] [Abstract][Full Text] [Related]
12. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
13. Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growth.
Chastagner P; Moreau JL; Jacques Y; Tanaka T; Miyasaka M; Kondo M; Sugamura K; Thèze J
Eur J Immunol; 1996 Jan; 26(1):201-6. PubMed ID: 8566067
[TBL] [Abstract][Full Text] [Related]
14. Early immune response and regulation of IL-2 receptor subunits.
Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
[TBL] [Abstract][Full Text] [Related]
15. Intermediate- and high-affinity interleukin-2 receptors expressed in an IL-4-dependent T-cell line induce different signals.
Rebollo A; Silva A
Immunology; 1993 Oct; 80(2):229-35. PubMed ID: 8262551
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.
Wei LH; Kuo ML; Chen CA; Chou CH; Lai KB; Lee CN; Hsieh CY
Oncogene; 2003 Mar; 22(10):1517-27. PubMed ID: 12629515
[TBL] [Abstract][Full Text] [Related]
17. Non random activation of endogenous interleukin-2, (IL-2), IL-2 receptor alpha and IL-2 receptor beta genes after transfection of mouse fibroblasts with a cDNA for the alpha chain of the human IL-2 receptor.
Han D; Plaisance S; Rubinstein E; Alileche A; Pottin-Clemenceau C; Kim TS; Cohen EP; Jasmin C; Azzarone B
Eur J Immunol; 1995 Jul; 25(7):1905-12. PubMed ID: 7621867
[TBL] [Abstract][Full Text] [Related]
18. Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer.
Nozaki S; Sledge GW; Nakshatri H
Biochem Biophys Res Commun; 2000 Aug; 275(1):60-2. PubMed ID: 10944441
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of interleukin-2 receptor gene-transduced peripheral blood lymphocytes on human ovarian cancer cells.
Ye D; Xie X; Lu W; Chen H; Cheng B
Chin Med J (Engl); 2001 Mar; 114(3):303-7. PubMed ID: 11780319
[TBL] [Abstract][Full Text] [Related]
20. Endocytosis of the beta chain of interleukin-2 receptor requires neither interleukin-2 nor the gamma chain.
Hémar A; Lieb M; Subtil A; DiSanto JP; Dautry-Varsat A
Eur J Immunol; 1994 Sep; 24(9):1951-5. PubMed ID: 8088315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
